Search research articles
Contact Us
Filters
Showing results (271-280 of 461) with videos related to
Page
of 47
Sort By:
The American Journal of Psychiatry
|
June 1, 1989
Hypersensitivity to carbon dioxide in panic disorder
L A Papp, R Goetz, R Cole, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 23, 2015
Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
K A Papp, K Barber, R Bissonnette, et al.
The British Journal of Dermatology
|
August 29, 2012
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
K A Papp, A Menter, B Strober, et al.
International Journal of Dermatology
|
May 17, 2006
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial
Kim A Papp, Reni Bressinck, Scott Fretzin, et al.
Dermatology and Therapy
|
March 6, 2020
Correction to: Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study
Bruno Falissard, Eric L Simpson, Emma Guttman-Yassky, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2021
Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2)
Kim A Papp, Sascha Gerdes, Craig L Leonardi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 18, 2013
Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study
K A Papp, M Sundaram, Y Bao, et al.
Journal of Psychiatric Research
|
January 1, 1988
Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research
M R Liebowitz, A J Fyer, J M Gorman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 8, 2018
Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial
K A Papp, A Blauvelt, A B Kimball, et al.
Psychiatry Research
|
August 1, 1989
Do panic disorder patients indiscriminately endorse somatic complaints?
R R Goetz, J M Gorman, D J Dillon, et al.
Page
of 47
Search research articles
Search
Showing results (271-280 of 461) with videos related to
Sort By:
Page
of 47
The American Journal of Psychiatry
|
June 1, 1989
Hypersensitivity to carbon dioxide in panic disorder
L A Papp, R Goetz, R Cole, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 23, 2015
Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
K A Papp, K Barber, R Bissonnette, et al.
The British Journal of Dermatology
|
August 29, 2012
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
K A Papp, A Menter, B Strober, et al.
International Journal of Dermatology
|
May 17, 2006
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial
Kim A Papp, Reni Bressinck, Scott Fretzin, et al.
Dermatology and Therapy
|
March 6, 2020
Correction to: Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study
Bruno Falissard, Eric L Simpson, Emma Guttman-Yassky, et al.
Journal of Drugs in Dermatology : JDD
|
August 16, 2021
Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2)
Kim A Papp, Sascha Gerdes, Craig L Leonardi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 18, 2013
Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study
K A Papp, M Sundaram, Y Bao, et al.
Journal of Psychiatric Research
|
January 1, 1988
Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research
M R Liebowitz, A J Fyer, J M Gorman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 8, 2018
Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial
K A Papp, A Blauvelt, A B Kimball, et al.
Psychiatry Research
|
August 1, 1989
Do panic disorder patients indiscriminately endorse somatic complaints?
R R Goetz, J M Gorman, D J Dillon, et al.
Page
of 47